A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
Cefmenoxime has been studied across 10 research domains including 😴 Sleep, 🧠 Focus & Attention, 🫘 Kidney, 🫁 Respiratory, 🔬 Oncology. The primary research focus is 😴 Sleep with 7% of studies addressing this area.
The following compounds share molecular targets with Cefmenoxime, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Cefmenoxime is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.